Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.40 |
| ▸ | IDH1 | O75874 | 4/20 | 0.39 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 3/20 | 0.35 |
| ▸ | NOS1 | P29475 | 2/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 8/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
| ▸ | XIAP | P98170 | 1/20 | 0.32 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20557114 | 1.00 | ASIC3 (0.40) | ASIC3IDH1MAP3K5NOS3NOS1 | |
| SCHEMBL20557224 | 0.81 | GABRA1 (0.37) | MAP3K5PIK3CD | |
| SCHEMBL30433540 | 0.81 | GABRA1 (0.37) | MAP3K5PIK3CD | |
| SCHEMBL29265520 | 0.76 | ASIC3 (0.41) | ASIC3IDH1NOS3NOS1NOS2 | |
| SCHEMBL21723787 | 0.75 | MAP3K5 (0.44) | ASIC3IDH1MAP3K5NOS3NOS1 | |
| Hydrochloric Acid SCHEMBL21724146 | 0.74 | MAP3K5 (0.43) | ASIC3IDH1MAP3K5NOS3NOS1 | |
| Hydrochloric Acid SCHEMBL21724144 | 0.73 | MAP3K5 (0.43) | ASIC3IDH1MAP3K5NOS3NOS1 | |
| SCHEMBL30433830 | 0.72 | MAP3K5 (0.54) | MAP3K5 | |
| SCHEMBL20557315 | 0.72 | MAP3K5 (0.54) | MAP3K5 | |
| SCHEMBL28368621 | 0.69 | PIK3CA (0.43) | ASIC3IDH1NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110869017-B | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | 英安塔制药有限公司 | 2023-05-05 | — | — | CN | disclosed |